Ledger.Open graph →

SEC Form D · filed January 28, 2021

TScan Therapeutics, Inc

Offering

$100.0M

Sold

$100.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Waltham, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Nandita Shangari · Waltham, MADirector Timothy Barberich · Boston, MADirector Ittai Harel · Lexington, MADirector Christoph Westphal · Boston, MADirector Brian Silver · New York, NYDirector Doug Fambrough · Waltham, MADirector David Southwell · Boston, MAExec · Director Andrew Hedin · Cambridge, MADirector Ittai Harel · Waltham, MADirector Nandita Shangari · Waltham, MADirector Christoph Westphal · Boston, MADirector Brian Silver · Waltham, MADirector Doug Fambrough · Waltham, MADirector Timothy Barberich · Framingham, MADirector David Southwell · Waltham, MAExec · Director Andrew Hedin · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗